Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treat-and-resect Study of Echo Decorrelation Imaging-controlled Radiofrequency Ablation in Liver Tumors

NCT05211388 is registered in ClinicalTrials.gov with University of Cincinnati as lead sponsor.

NCT NCT05211388
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05211388 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treat-and-resect Study of Echo Decorrelation Imaging-controlled Radiofrequency Ablation in Liver Tumors
Lead sponsor
University of Cincinnati
Phase
Not applicable
Overall status
Withdrawn
Start date
July 11, 2022
Completion date
January 15, 2024
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

liver tumor